Literature DB >> 30957722

Clear cell urothelial carcinoma of the urinary bladder - a rare pathological entity. A case report and a systematic review of the literature.

Ioana Mihai1, Sorina Taban, Alin Cumpanas, Emilian Gh Olteanu, Mihaela Iacob, Alis Dema.   

Abstract

The most common histological type of urinary bladder cancer is urothelial carcinoma (UC). In contrast, the clear cell variant of urothelial carcinoma (CCUC) is quite a rare neoplasm. In this study, we report a case of an 81-year-old male, presenting with gross hematuria and acute urinary retention, which was subsequently diagnosed with CCUC at our pathology department. Furthermore, we provide a short systematic review of the literature (PubMed, Scopus, and Science Citation Index) for this rare histopathological entity and a brief discussion about its morphological and immunohistochemical (IHC) characteristics.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30957722      PMCID: PMC6868491          DOI: 10.17305/bjbms.2019.4182

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  14 in total

1.  Hepatocyte nuclear factor-1β expression in clear cell adenocarcinomas of the bladder and urethra: diagnostic utility and implications for histogenesis.

Authors:  Fadi Brimo; Mehsati Herawi; Rajni Sharma; Georges J Netto; Jonathan I Epstein; Peter B Illei
Journal:  Hum Pathol       Date:  2011-04-14       Impact factor: 3.466

2.  Clear-cell transitional cell carcinoma.

Authors:  K G Braslis; A Jones; D Murphy
Journal:  Aust N Z J Surg       Date:  1997-12

3.  Clear cell carcinoma of the bladder in a patient with a earlier clear cell renal cell carcinoma: a case report with morphologic, immunohistochemical, and cytogenetical analysis.

Authors:  Matteo Rotellini; Cristina Fondi; Milena Paglierani; Niceta Stomaci; Maria Rosaria Raspollini
Journal:  Appl Immunohistochem Mol Morphol       Date:  2010-07

4.  Transitional cell carcinoma exhibiting clear cell features. A differential diagnosis for clear cell adenocarcinoma of the urinary tract.

Authors:  S N Kotliar; C G Wood; A J Schaeffer; R Oyasu
Journal:  Arch Pathol Lab Med       Date:  1995-01       Impact factor: 5.534

5.  Urothelial carcinoma (clear cell variant) diagnosed with useful immunohistochemistry stain.

Authors:  Ryo Yamashita; Raizou Yamaguchi; Keiji Yuen; Masashi Niwakawa; Kenichi Tobisu
Journal:  Int J Urol       Date:  2006-11       Impact factor: 3.369

Review 6.  Primary multiple clear cell variant urothelial carcinomas of urinary bladder: a rare case report.

Authors:  Yutao Zhang; Jun Huang; Hao Feng; Yun Tang
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

Review 7.  Adenocarcinoma of the urinary bladder.

Authors:  Vipulkumar Dadhania; Bogdan Czerniak; Charles C Guo
Journal:  Am J Clin Exp Urol       Date:  2015-08-08

8.  Clear Cell Urothelial Carcinoma.

Authors:  Kien T Mai; Justin Bateman; Bojana Djordjevic; Trevor A Flood; Eric C Belanger
Journal:  Int J Surg Pathol       Date:  2016-07-28       Impact factor: 1.271

Review 9.  Clear cell urothelial carcinoma of the urinary bladder: a case report and review of the literature.

Authors:  Virginia M Knez; Willis Barrow; M Scott Lucia; Shandra Wilson; Francisco G La Rosa
Journal:  J Med Case Rep       Date:  2014-08-14

10.  Clear-cell variant urothelial carcinoma of the bladder: a case report and review of the literature.

Authors:  Mario W Kramer; Mahmoud Abbas; Stefanie Pertschy; Jan Ulrich Becker; Hans-Heinrich Kreipe; Markus A Kuczyk; Axel S Merseburger; Hossein Tezval
Journal:  Rare Tumors       Date:  2012-10-10
View more
  2 in total

1.  Acute urinary retention and risk of cancer: population based Danish cohort study.

Authors:  Maria Bisgaard Bengtsen; Dóra Körmendiné Farkas; Michael Borre; Henrik Toft Sørensen; Mette Nørgaard
Journal:  BMJ       Date:  2021-10-19

2.  Cases - Clear-cell urothelial carcinoma of the bladder.

Authors:  Carolyn MacLeod; Ernest P Chan; Kamilia Rizkalla; Alp Sener; Jeffrey Campbell
Journal:  Can Urol Assoc J       Date:  2021-12       Impact factor: 1.862

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.